Development
e-therapeutics plc
ETXPF
OTC PK
07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.31% | -19.98% | 7.16% | 37.25% | -3.07% |
Total Receivables | 2.29% | 19.03% | 7.15% | 30.17% | -3.09% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 2.31% | 19.41% | 7.16% | -7.20% | -3.07% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 2.31% | 72.61% | 7.16% | -35.11% | -3.07% |
Total Current Assets | 2.31% | -14.96% | 7.16% | 29.80% | -3.07% |
|
|||||
Total Current Assets | 2.31% | -14.96% | 7.16% | 29.80% | -3.07% |
Net Property, Plant & Equipment | 2.32% | -55.35% | 7.16% | -38.75% | -3.07% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 2.33% | 28.53% | 7.17% | 24.07% | -3.11% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 2.31% | -15.13% | 7.16% | 28.11% | -3.07% |
|
|||||
Total Accounts Payable | 2.31% | 182.17% | 7.14% | -41.08% | -3.07% |
Total Accrued Expenses | -- | -- | 7.16% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 2.39% | -68.88% | 7.17% | -31.19% | -3.07% |
Total Finance Division Other Current Liabilities | -- | -- | 7.17% | -- | -- |
Total Other Current Liabilities | -- | -- | 7.17% | -- | -- |
Total Current Liabilities | 2.31% | -18.41% | 7.16% | 37.96% | -3.07% |
|
|||||
Total Current Liabilities | 2.31% | -18.41% | 7.16% | 37.96% | -3.07% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -3.04% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.31% | -18.41% | 7.16% | 27.57% | -3.07% |
|
|||||
Common Stock & APIC | 2.31% | 2.08% | 7.16% | 7.20% | -3.07% |
Retained Earnings | -2.31% | -9.10% | -7.16% | -0.43% | 3.07% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 2.31% | -14.97% | 7.16% | 28.13% | -3.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.31% | -14.97% | 7.16% | 28.13% | -3.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 2.31% | -14.97% | 7.16% | 28.13% | -3.07% |
|